Article Details

Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron ...

Retrieved on: 2024-08-08 20:57:20

Tags for this article:

Click the tags to see associated articles and topics

Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron .... View article details on hiswai:

Excerpt

Remdesivir (Veklury, GS-5734) is an intravenous antiviral that initially received U.S. Food and Drug Administration (FDA) approval as a 5–10 day ...

Article found on: bmcinfectdis.biomedcentral.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo